Clinical trial registry record

Study in Elderly Patients With Early Breast Cancer (ICE)

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 3 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 17, 2014.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT00196859
Last registry update
July 17, 2014
Status
Completed
Phase
Phase 3
Sponsor
GBG Forschungs GmbH
Enrollment
1500
Countries
Germany
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 3
Study design
RANDOMIZED · PARALLEL · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
1500
Population
FEMALE · 65 Years
Duration
2004-06-01 to 2014-01-01
Intervention
Ibandronate, Capecitabine; Ibandronate
Comparator
A
Outcomes measured
Any local or distant relapse of breast cancer, any second malignancy, and any death irrespective of its cause; Any death related and not-related to breast cancer; Any premature treatment discontinuation of capecitabine or ibandronate; Any grade II to grade IV AE specified to serious or non serious events; Every bone fracture, bone surgery, new diagnosis of osteoporosis; Completed months of i.v. or p.o. treatment with ibandronate; Frequency of changes of preference of Ibandronate application; Evaluation according to EORTC Q 30
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 3A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

cancer and aging
Read the original source →Export JSON